Lars Olaf Cardell
Quick facts
Phase 2 pipeline
- ALK Alutard 5-grasses · Allergy
ALK Alutard 5-grasses is an immunotherapy that targets the CD25 antigen. - SLIT Grazax ALK Nordic 75 000 SQ-T
Phase 1 pipeline
- ALK Alutard 5-grasses and birch
Allergen immunotherapy that induces immune tolerance by gradually exposing the immune system to increasing doses of grass and birch pollen allergens.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies